Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-125528
Filing Date
2022-12-08
Accepted
2022-12-08 17:02:15
Documents
6
Period of Report
2023-01-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2230798-2_def14a.htm DEF 14A 2195801
2 GRAPHIC sg_forvisllp-bw.jpg GRAPHIC 13909
3 GRAPHIC tm2230798d2-px_01page4c.jpg GRAPHIC 700874
4 GRAPHIC tm2230798d2-px_02page4c.jpg GRAPHIC 658252
5 GRAPHIC tm2230798d2-px_03page4c.jpg GRAPHIC 466075
6 GRAPHIC tm2230798d2-px_04page4c.jpg GRAPHIC 546470
  Complete submission text file 0001104659-22-125528.txt   5480115
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 221453088
SIC: 2836 Biological Products, (No Diagnostic Substances)